Developer docs
API playgroundTry for free, no card

Search company profiles

STADA Poland

Full company profile

uuid00vn7w4

Namestring
STADA Poland
Legal namestring
STADA Pharm Sp. z o.o.
Websiteurl
stadapoland.pl
Company typeenum
Private
Founded yearstring
-
Descriptiontext

STADA Poland is the Polish subsidiary of STADA Arzneimittel AG, a German pharmaceutical conglomerate listed on the Frankfurt Stock Exchange and operating in approximately 120 countries with roughly 12,300 employees worldwide. The Polish business markets prescription medicines, over-the-counter (OTC) drugs, medical devices, cosmetics and dietary supplements across cardiovascular, pain/CNS, dermatology, respiratory, and consumer health categories, serving both pharmacy retailers and end consumers in Poland through wholesale intermediaries (e.g., NEUCA) and an in-house field sales organization.

The portfolio is built on a mix of STADA-developed generics and a series of established consumer healthcare brands acquired from major pharmaceutical companies between March and October 2020 — Walmark, plus Cholinex, Orofar and Venoruton from GSK, Nizoral from Johnson & Johnson, and Modafen and Acodin from Sanofi. Additional pipeline exposure to specialty and biologic therapeutics is being built through biosimilar development partnerships with Alvotech, mAbxience (Insud) and Xbrane. The Polish operations are headquartered in Warsaw (ul. Krakowiaków 44, 02-255 Warszawa), with two legal entities (STADA Pharm Sp. z o.o. and STADA Poland Sp. z o.o.) whose announced merger was dated September 26, 2023; a new office was opened at The Park Warsaw in May 2021, and Paulina Romaniszyn has served as Country Head & General Manager since September 2020.

The business model is one-time product sales through pharmacy distribution channels, with revenue generated when wholesalers and pharmacies purchase branded generics, OTC SKUs, and consumer healthcare products for resale to Polish consumers. The company pursues growth through brand acquisitions, geographic and category expansion of the consumer health portfolio, and pipeline additions via biosimilar partnerships, while leveraging the parent group's scale in regulatory affairs, manufacturing, and supply chain to compete with both local Polish generics manufacturers and larger multinational pharmaceutical companies.

Short descriptiontext

STADA Poland is the Polish subsidiary of German pharmaceutical conglomerate STADA Arzneimittel AG, marketing prescription drugs, OTC products, medical devices, cosmetics, and dietary supplements through pharmacy wholesale channels across Poland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWarszawa, Poland
HQ citystring
Warszawa
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, OTC consumer healthcare, prescription medicines, medical devices, dietary supplements
Industry3 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic and specialty pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

STADA Poland generates revenue through the sale of prescription medications (leki na receptę), OTC products (leki bez recepty), medical devices (wyroby medyczne), cosmetics (kosmetyki), and dietary supplements (suplementy diety). The company operates a two-pillar strategy covering generic drugs including specialist medicines and consumer healthcare products available without prescription.

stadapoland.pl
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1Orofar
Description

Throat lozenges and sprays for sore throat relief and oral infections

stadapoland.pl
+12 more records
Core offering1 text field

STADA Poland develops and markets a two-pillar portfolio of (1) generic and specialty prescription medicines covering pain, cardiovascular, CNS, urology, oncology, and infectious disease therapeutics, and (2) consumer healthcare OTC products, medical devices, cosmetics, and dietary supplements. Its products are sold through pharmaceutical wholesalers and pharmacy retail in Poland under established brands such as Cholinex, Orofar, Nizoral, ITAMI, Venoruton, Mobilat, Hirudoid, Oilatum, Sinulan, and Hedrin.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

STADA Poland operates as part of STADA AG, a German pharmaceutical conglomerate, offering a two-pronged strategy covering generic medicines (including specialty pharmaceuticals) and consumer healthcare products available without prescription. The company provides prescription medications across therapeutic areas including cardiovascular health (anticoagulants like Dabigatran and Axipio, pain management like Tramal and Palexia), central nervous system disorders, urology, and diabetes. The OTC portfolio includes throat lozenges (Cholinex, Orofar), dermatological products (Nizoral for antifungal treatment), muscle and joint treatments (ITAMI, Mobilat, Elmetacin), and venous products (Hirudoid, Venoruton). Medical devices include Sinulan sinus relief products and Hedrin head lice treatments. Cosmetics encompass the Oilatum sensitive skin care line and Nizoral Daily Care hair care products. Dietary supplements include Sinulan respiratory products, Lactostad probiotics, and various vitamins and minerals (Biotin, Zinc, Selenium, Vitamin D3). The company's strategic focus areas include pain treatment (Partner in Pain Treatment), biosimilar development, and expansion of the Consumer Healthcare brand portfolio through acquisitions from GSK and Sanofi.

Product and service59 records
1Cholinex®
CategoryOTC medicine
Description

Throat lozenges indicated for inflammation of the oral cavity and throat, throat pain and swelling, and antibiotic therapy for infections of the mucous membrane. Sold OTC through Polish pharmacies for sore throat and oral inflammation relief.

2ITAMI®
CategoryOTC medicine
Description

Self-adhesive plaster containing 140 mg diclofenac for topical use, providing analgesic and anti-inflammatory effects for muscles and joints. Sold OTC through Polish pharmacies.

3Nizoral®
CategoryOTC medicine
Description

Medicinal shampoo containing 20 mg ketoconazole for topical application on skin, indicated for dandruff and fungal infections. Sold OTC through Polish pharmacies.

4Orofar Max
CategoryOTC medicine
Description

Throat lozenges indicated for antiseptic treatment of throat and oral cavity inflammation and relief of pain associated with these conditions. Sold OTC through Polish pharmacies.

5Orofar Junior
CategoryOTC medicine
Description

Throat lozenges for children indicated for oral infections, sore throat associated with colds, pharyngitis, laryngitis, and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.

6Cynk organiczny 15 mg
CategoryDietary supplement
Description

Organic zinc supplement containing 15 mg per tablet, sold through Polish pharmacies as a dietary supplement.

7Herba-Imuno
CategoryDietary supplement
Description

Herbal immune support supplement, sold through Polish pharmacies as a dietary supplement.

8Orofar® Total Action
CategoryOTC medicine
Description

Spray indicated for oral cavity infections including gum inflammation, infections and ulcers of the oral mucosa (canker sores), and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.

9Acodin®
CategoryOTC medicine
Description

Cough suppressant containing dextromethorphan indicated for periodic suppression of non-productive (dry) cough from various origins including colds and pleural cough. Sold OTC through Polish pharmacies.

10Acodin® Duo
CategoryOTC medicine
Description

Combines dextromethorphan and dexpanthenol to suppress cough and positively influence regeneration of respiratory mucous membranes. Sold OTC through Polish pharmacies.

11Cholinex® bez cukru
CategoryOTC medicine
Description

Sugar-free throat lozenges indicated for inflammation of the oral cavity and throat, pain and swelling of the throat, and dental treatment of gingival inflammation. Sold OTC through Polish pharmacies.

12Cholinex® Intense
CategoryOTC medicine
Description

Throat lozenges indicated for pain and throat inflammation, available in honey-lemon and blackberry flavors. Sold OTC through Polish pharmacies.

13Elmetacin®
CategoryOTC medicine
Description

External aerosol spray containing 1% indomethacin solution with anti-edema effects for muscles and joints. Sold OTC through Polish pharmacies.

14Hirudoid®
CategoryOTC medicine
Description

Available as ointment and gel, with main component mucopolysaccharide polysulfate, providing anti-inflammatory, antithrombotic, and regenerative effects for venous conditions. Sold OTC through Polish pharmacies.

15Mobilat®
CategoryOTC medicine
Description

Triple-component ointment or gel for topical use containing salicylic acid, adrenal cortex extract, and mucopolysaccharide polysulfate, providing analgesic and anti-edema effects. Sold OTC through Polish pharmacies.

16Nizoral® Krem
CategoryOTC medicine
Description

Cream containing 20 mg/g ketoconazole indicated for topical treatment of fungal skin infections and seborrheic dermatitis. Sold OTC through Polish pharmacies.

17Oilatum® 634 mg/g
CategoryOTC medicine
Description

Bath emulsion indicated for local treatment of irritated, dry, itchy, and flaking skin, also indicated for infant bathing. Sold OTC through Polish pharmacies.

18Permen® Med Forte
CategoryOTC medicine
Description

Used for treating erectile dysfunction in adult men, defined as the inability to obtain or maintain sufficient penile erection for sexual intercourse. Sold OTC through Polish pharmacies.

19Venoruton® forte
CategoryOTC medicine
Description

Tablet medication that protects venous vessels, stabilizes venous walls, and reduces edema. Used for leg edema, venous insufficiency (leg varicose veins), and hemorrhoids. Sold OTC through Polish pharmacies.

20Dabigatran Eteksylan STADA
CategoryPrescription medicine
Description

Available in 75mg, 110mg, and 150mg hard capsule forms (Dabigatranum etexilatum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.

21Palexia Retard
CategoryPrescription medicine
Description

Available in 50mg, 100mg, 150mg, 200mg, and 250mg extended-release tablet forms (Tapentadol), an analgesic for moderate to severe pain. Dispensed by prescription through Polish pharmacies.

22Tramal/Tramal Retard
CategoryPrescription medicine
Description

Tramadol hydrochloride products available as oral drops (10ml, 96ml) and extended-release tablets (50mg, 100mg, 150mg, 200mg), an analgesic. Dispensed by prescription through Polish pharmacies.

23Transtec
CategoryPrescription medicine
Description

Transdermal patch system available in 35μg/h, 52.5μg/h, and 70μg/h doses (Buprenorphinum), for pain management. Dispensed by prescription through Polish pharmacies.

24Versatis
CategoryPrescription medicine
Description

700mg medicated plaster (Lidocainum) for topical pain relief. Dispensed by prescription through Polish pharmacies.

25Axipio
CategoryPrescription medicine
Description

Available in 2.5mg and 5mg film-coated tablets (Apixabanum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.

26Lecytyna Forte
CategoryDietary supplement
Description

1200mg lecithin supplement for cognitive function support, sold through Polish pharmacies as a dietary supplement.

27Ximluci
CategoryPrescription medicine
Description

(Ranibizumab) 10 mg/ml solution for injection, administered by qualified ophthalmologists for intravitreal injections. Dispensed by prescription through specialist ophthalmology channels in Poland.

28Zaldiar
CategoryPrescription medicine
Description

37.5/325mg film-coated tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.

29Zaldiar Effervescent
CategoryPrescription medicine
Description

37.5/325mg effervescent tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.

30Kefdensis
CategoryPrescription medicine
Description

60mg Denosumab solution for injection in pre-filled syringes for osteoporosis treatment. Dispensed by prescription through Polish pharmacies and clinics.

31Kinpeygo
CategoryPrescription medicine
Description

4mg Budesonide modified-release hard capsules for kidney disease treatment. Dispensed by prescription through Polish pharmacies and clinics.

32Posaconazole Stada
CategoryPrescription medicine
Description

40 mg/ml oral suspension (Posaconazolum), an antifungal medication. Dispensed by prescription through Polish pharmacies.

33Flexove
CategoryPrescription medicine
Description

625mg Glucosamine film-coated tablets for joint health. Dispensed by prescription through Polish pharmacies.

34Dobroson
CategoryPrescription medicine
Description

7.5mg Zopiclone film-coated tablets for sleep disorders. Dispensed by prescription through Polish pharmacies.

35Acodin® Junior
CategoryPrescription medicine
Description

Syrup containing 7.5mg dextromethorphan hydrobromide and 50mg dexpanthenol per 5ml for cough treatment in children. Dispensed by prescription through Polish pharmacies.

36Sinulan Express Forte
CategoryMedical device
Description

Product for nasal/sinus relief distributed through Polish pharmacies as a medical device.

37Sinulan Express Forte Junior
CategoryMedical device
Description

Junior version of sinus relief product distributed through Polish pharmacies as a medical device.

38Hedrin® OCHRONA
CategoryMedical device
Description

Head lice protection product distributed through Polish pharmacies as a medical device.

39Hedrin® SZAMPON
CategoryMedical device
Description

Medicated shampoo for head lice treatment distributed through Polish pharmacies as a medical device.

40Hedrin® RAZ
CategoryMedical device
Description

Head lice treatment product in gel form distributed through Polish pharmacies as a medical device.

41Nizoral® Daily Care odżywka
CategoryCosmetics
Description

Nizoral daily conditioner for hair care, sold through Polish pharmacies as a cosmetic.

42Nizoral® Daily Care Szampon
CategoryCosmetics
Description

Nizoral daily shampoo for regular hair and scalp care, sold through Polish pharmacies as a cosmetic.

43Oilatum® Formuła Zaawansowana Emulsja
CategoryCosmetics
Description

Advanced formula bath emulsion for sensitive and dry skin, sold through Polish pharmacies as a cosmetic.

44Oilatum® Formuła MED. Krem
CategoryCosmetics
Description

Medical formula cream for dry and sensitive skin, sold through Polish pharmacies as a cosmetic.

45Oilatum® Codzienna Ochrona Emolient w kostce
CategoryCosmetics
Description

Daily protection emollient soap bar for gentle cleansing, sold through Polish pharmacies as a cosmetic.

46Oilatum® Codzienna Ochrona Płyn do kąpieli
CategoryCosmetics
Description

Daily protection bath liquid for moisturizing and skin protection, sold through Polish pharmacies as a cosmetic.

47Oilatum® Codzienna Ochrona Żel do mycia głowy i ciała
CategoryCosmetics
Description

Daily protection head and body wash gel for gentle cleansing, sold through Polish pharmacies as a cosmetic.

48Sinulan Forte
CategoryDietary supplement
Description

Plant-based preparation supporting proper functioning of the upper respiratory tract, sold through Polish pharmacies as a dietary supplement.

49Sinulan Duo Forte
CategoryDietary supplement
Description

Dual-action formula for respiratory tract support, sold through Polish pharmacies as a dietary supplement.

50Biotyna 300 µg
CategoryDietary supplement
Description

Biotin supplement containing 300 mcg per tablet, sold through Polish pharmacies as a dietary supplement.

51Omega 3-6-9
CategoryDietary supplement
Description

Combined omega-3, omega-6, and omega-9 fatty acid supplement, sold through Polish pharmacies as a dietary supplement.

52Selen Organiczny
CategoryDietary supplement
Description

Organic selenium supplement containing 100 mcg per tablet, sold through Polish pharmacies as a dietary supplement.

53Sylimarin Max
CategoryDietary supplement
Description

Maximum strength silymarin supplement (150mg) for liver support, sold through Polish pharmacies as a dietary supplement.

54Urinal Intensiv
CategoryDietary supplement
Description

Intensive urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.

55Urinal
CategoryDietary supplement
Description

Standard urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.

56Witamina D3 2000
CategoryDietary supplement
Description

Vitamin D3 supplement providing 2000 IU per tablet, sold through Polish pharmacies as a dietary supplement.

57Lactostad dla dzieci
CategoryDietary supplement
Description

Probiotic supplement designed for children, sold through Polish pharmacies as a dietary supplement.

58Lactostad dla dorosłych
CategoryDietary supplement
Description

Probiotic supplement designed for adults, sold through Polish pharmacies as a dietary supplement.

59Sinulan plaster aromatyczny Junior
CategoryOther
Description

Aromatic nasal strip for children for easier breathing during colds, sold through Polish pharmacies.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1NEUCA
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-09-13
Description

NEUCA is the largest pharmaceutical wholesaler in Poland. STADA Poland was the General Partner (Partner Generalny) at the Gala Farmaceuty organized by NEUCA in September 2021 at the Warsaw Hilton hotel. The event was attended by 280 owners representing nearly 1,000 pharmacies, providing STADA with opportunities to showcase its product portfolio and build long-term customer relationships.

stadapoland.pl
2Sanofi
Strategic tierCoreTypeOthersAnnounced on2020-10-01
Description

STADA finalized the acquisition of approximately a dozen consumer brands from Sanofi in 13 European countries. In Poland, the acquired brands include Modafen and Acodin. The transaction did not include production assets or employees.

stadapoland.pl
3GlaxoSmithKline (GSK)
Strategic tierCoreTypeOthersAnnounced on2020-06-01
Description

STADA acquired from GSK a portfolio of 15 OTC products in over 50 countries globally. In Poland, this included the brands Orofar, Cholinex, and Venoruton, significantly expanding STADA Poland's consumer healthcare portfolio.

stadapoland.pl
4Walmark
Strategic tierCoreTypeOthersAnnounced on2020-03-01
Description

Walmark merged with STADA in March 2020. This merger consolidated employees who were previously working in three different locations into a single unified office under the One STADA philosophy. The Walmark portfolio included brands such as Sinulan Forte and Lactostad.

stadapoland.pl
5Alvotech
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alvotech is a biotech company specializing in biosimilar development. STADA collaborates with Alvotech as part of its biosimilar research program aimed at becoming a key player in the biosimilar segment, particularly for oncology treatments such as filgrastim and pegfilgrastym.

stadapoland.pl
6mAbxience (Insud)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Part of STADA's biosimilar development collaboration program. mAbxience specializes in biosimilar monoclonal antibodies. STADA aims to leverage this partnership to expand its presence in the biosimilar segment.

stadapoland.pl
7Xbrane
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Xbrane collaborates with STADA on biosimilar development. This partnership is part of STADA's strategy to build capabilities in the biosimilar market segment.

stadapoland.pl
8Johnson & Johnson
Strategic tierCoreTypeOthers
Description

STADA acquired the Nizoral brand from Johnson & Johnson as part of its expansion of the consumer healthcare portfolio in Poland.

stadapoland.pl
9Kantar
Strategic tierMinorTypeOthers
Description

Kantar is the market research agency commissioned by STADA to conduct the annual STADA Health Report. The 2021 edition surveyed 30,000 respondents from 15 European countries including Poland on health-related topics including pandemic effects on daily life.

stadapoland.pl
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Polpharma
TypeDirect peer
Description

Poland's largest generic pharmaceutical manufacturer, producing prescription generics, OTC, and dietary supplements with a similarly broad therapeutic portfolio and pharmacy-led distribution model — directly comparable to STADA Poland's two-pillar strategy.

2Teva Poland
TypeDirect peer
Description

Teva is the world's leading generics company and a top-tier player in the Polish prescription generic and specialty market. It competes head-on with STADA Poland across therapeutic categories and pharmacy channels.

3Sandoz Poland (Novartis)
TypeDirect peer
Description

Sandoz is Novartis's generics division and a major prescription generic and biosimilar competitor in Poland. It mirrors STADA Poland's generic-plus-specialty positioning, particularly in biosimilars.

4KRKA Poland
TypeDirect peer
Description

KRKA is a Slovenian generic and OTC pharmaceutical group with a strong Polish subsidiary. It competes with STADA Poland across prescription generics, OTC, and self-medication categories.

5Gedeon Richter Poland
TypeDirect peer
Description

Gedeon Richter's Polish subsidiary markets a broad portfolio of generics and specialty pharmaceuticals, including CNS and women's health. It is a comparable Eastern European generic peer with similar pharmacy-led distribution.

6Viatris Poland (formerly Mylan)
TypeDirect peer
Description

Viatris is a global generics and specialty player with a Polish commercial presence, directly competing with STADA Poland in generic prescriptions and selected OTC categories.

7Zentiva Poland
TypeDirect peer
Description

Zentiva (formerly Sanofi's European generics business) is a pan-European generic manufacturer with a Polish footprint, directly competing with STADA Poland across generic Rx and self-medication.

8USP Zdrowie (Pelion)
TypeRegional player
Description

USP Zdrowie is a major Polish OTC, supplement, and cosmetics manufacturer, part of the Pelion group that also operates the CEPD/wholesale network. It is a strong domestic peer with overlapping OTC and dietary supplement categories.

9Perrigo Poland
TypeBroad incumbent
Description

Perrigo is a global OTC and self-care leader; its Polish subsidiary markets OTC and consumer healthcare products (e.g., Analgesics, cold & flu). It is a broad incumbent comparable in OTC portfolio shape and pharmacy-channel go-to-market.

10Aflofarm Poland
TypeRegional player
Description

Aflofarm is one of the leading Polish OTC and dietary supplement manufacturers with strong domestic brands (e.g., Apap, Strepsils-adjacent SKUs). It is a regional OTC/supplement peer that competes for pharmacy shelf space and consumer mindshare.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

STADA Poland

Generic and specialty pharmaceuticalsstadapoland.pl

STADA Poland is the Polish subsidiary of German pharmaceutical conglomerate STADA Arzneimittel AG, marketing prescription drugs, OTC products, medical devices, cosmetics, and dietary supplements through pharmacy wholesale channels across Poland.

What STADA Poland does

STADA Poland is the Polish subsidiary of STADA Arzneimittel AG, a German pharmaceutical conglomerate listed on the Frankfurt Stock Exchange and operating in approximately 120 countries with roughly 12,300 employees worldwide. The Polish business markets prescription medicines, over-the-counter (OTC) drugs, medical devices, cosmetics and dietary supplements across cardiovascular, pain/CNS, dermatology, respiratory, and consumer health categories, serving both pharmacy retailers and end consumers in Poland through wholesale intermediaries (e.g., NEUCA) and an in-house field sales organization.

The portfolio is built on a mix of STADA-developed generics and a series of established consumer healthcare brands acquired from major pharmaceutical companies between March and October 2020 — Walmark, plus Cholinex, Orofar and Venoruton from GSK, Nizoral from Johnson & Johnson, and Modafen and Acodin from Sanofi. Additional pipeline exposure to specialty and biologic therapeutics is being built through biosimilar development partnerships with Alvotech, mAbxience (Insud) and Xbrane. The Polish operations are headquartered in Warsaw (ul. Krakowiaków 44, 02-255 Warszawa), with two legal entities (STADA Pharm Sp. z o.o. and STADA Poland Sp. z o.o.) whose announced merger was dated September 26, 2023; a new office was opened at The Park Warsaw in May 2021, and Paulina Romaniszyn has served as Country Head & General Manager since September 2020.

The business model is one-time product sales through pharmacy distribution channels, with revenue generated when wholesalers and pharmacies purchase branded generics, OTC SKUs, and consumer healthcare products for resale to Polish consumers. The company pursues growth through brand acquisitions, geographic and category expansion of the consumer health portfolio, and pipeline additions via biosimilar partnerships, while leveraging the parent group's scale in regulatory affairs, manufacturing, and supply chain to compete with both local Polish generics manufacturers and larger multinational pharmaceutical companies.

STADA Poland firmographics

Firmographics
Name
STADA Poland
Legal name
STADA Pharm Sp. z o.o.
Website
https://stadapoland.pl
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
STADA Poland is the Polish subsidiary of German pharmaceutical conglomerate STADA Arzneimittel AG, marketing prescription drugs, OTC products, medical devices, cosmetics, and dietary supplements through pharmacy wholesale channels across Poland.
Ownership category
akta.pro rank

STADA Poland industry classification

Industry
Product category
Generic and specialty pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)

Keywords

  • Generic pharmaceuticals
  • OTC consumer healthcare
  • Prescription medicines
  • Medical devices
  • Dietary supplements

Where STADA Poland is headquartered

Location

Headquarters

HQ city
Warszawa
HQ country
Poland
HQ region
Europe

Offices2 records

Markets served

STADA Poland business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Pharmaceutical Product Sales: STADA Poland generates revenue through the sale of prescription medications (leki na receptę), OTC products (leki bez recepty), medical devices (wyroby medyczne), cosmetics (kosmetyki), and dietary supplements (suplementy diety). The company operates a two-pillar strategy covering generic drugs including specialist medicines and consumer healthcare products available without prescription.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

STADA Poland product offering

Product offering

Core offering

STADA Poland develops and markets a two-pillar portfolio of (1) generic and specialty prescription medicines covering pain, cardiovascular, CNS, urology, oncology, and infectious disease therapeutics, and (2) consumer healthcare OTC products, medical devices, cosmetics, and dietary supplements. Its products are sold through pharmaceutical wholesalers and pharmacy retail in Poland under established brands such as Cholinex, Orofar, Nizoral, ITAMI, Venoruton, Mobilat, Hirudoid, Oilatum, Sinulan, and Hedrin.

Product overview

STADA Poland operates as part of STADA AG, a German pharmaceutical conglomerate, offering a two-pronged strategy covering generic medicines (including specialty pharmaceuticals) and consumer healthcare products available without prescription. The company provides prescription medications across therapeutic areas including cardiovascular health (anticoagulants like Dabigatran and Axipio, pain management like Tramal and Palexia), central nervous system disorders, urology, and diabetes. The OTC portfolio includes throat lozenges (Cholinex, Orofar), dermatological products (Nizoral for antifungal treatment), muscle and joint treatments (ITAMI, Mobilat, Elmetacin), and venous products (Hirudoid, Venoruton). Medical devices include Sinulan sinus relief products and Hedrin head lice treatments. Cosmetics encompass the Oilatum sensitive skin care line and Nizoral Daily Care hair care products. Dietary supplements include Sinulan respiratory products, Lactostad probiotics, and various vitamins and minerals (Biotin, Zinc, Selenium, Vitamin D3). The company's strategic focus areas include pain treatment (Partner in Pain Treatment), biosimilar development, and expansion of the Consumer Healthcare brand portfolio through acquisitions from GSK and Sanofi.

Differentiator

Problem solved

Functional benefit

Brands

  • Orofar: Throat lozenges and sprays for sore throat relief and oral infections
  • Cholinex
  • Nizoral
  • ITAMI
  • Venoruton
  • Oilatum
  • Sinulan
  • Hedrin
  • Elmetacin
  • Mobilat
  • Hirudoid
  • Acodin
  • Permen Med

Products and services

  • Cholinex® Throat lozenges indicated for inflammation of the oral cavity and throat, throat pain and swelling, and antibiotic therapy for infections of the mucous membrane. Sold OTC through Polish pharmacies for sore throat and oral inflammation relief.
  • ITAMI® Self-adhesive plaster containing 140 mg diclofenac for topical use, providing analgesic and anti-inflammatory effects for muscles and joints. Sold OTC through Polish pharmacies.
  • Nizoral® Medicinal shampoo containing 20 mg ketoconazole for topical application on skin, indicated for dandruff and fungal infections. Sold OTC through Polish pharmacies.
  • Orofar Max Throat lozenges indicated for antiseptic treatment of throat and oral cavity inflammation and relief of pain associated with these conditions. Sold OTC through Polish pharmacies.
  • Orofar Junior Throat lozenges for children indicated for oral infections, sore throat associated with colds, pharyngitis, laryngitis, and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.
  • Cynk organiczny 15 mg Organic zinc supplement containing 15 mg per tablet, sold through Polish pharmacies as a dietary supplement.
  • Herba-Imuno Herbal immune support supplement, sold through Polish pharmacies as a dietary supplement.
  • Orofar® Total Action Spray indicated for oral cavity infections including gum inflammation, infections and ulcers of the oral mucosa (canker sores), and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.
  • Acodin® Cough suppressant containing dextromethorphan indicated for periodic suppression of non-productive (dry) cough from various origins including colds and pleural cough. Sold OTC through Polish pharmacies.
  • Acodin® Duo Combines dextromethorphan and dexpanthenol to suppress cough and positively influence regeneration of respiratory mucous membranes. Sold OTC through Polish pharmacies.
  • Cholinex® bez cukru Sugar-free throat lozenges indicated for inflammation of the oral cavity and throat, pain and swelling of the throat, and dental treatment of gingival inflammation. Sold OTC through Polish pharmacies.
  • Cholinex® Intense Throat lozenges indicated for pain and throat inflammation, available in honey-lemon and blackberry flavors. Sold OTC through Polish pharmacies.
  • Elmetacin® External aerosol spray containing 1% indomethacin solution with anti-edema effects for muscles and joints. Sold OTC through Polish pharmacies.
  • Hirudoid® Available as ointment and gel, with main component mucopolysaccharide polysulfate, providing anti-inflammatory, antithrombotic, and regenerative effects for venous conditions. Sold OTC through Polish pharmacies.
  • Mobilat® Triple-component ointment or gel for topical use containing salicylic acid, adrenal cortex extract, and mucopolysaccharide polysulfate, providing analgesic and anti-edema effects. Sold OTC through Polish pharmacies.
  • Nizoral® Krem Cream containing 20 mg/g ketoconazole indicated for topical treatment of fungal skin infections and seborrheic dermatitis. Sold OTC through Polish pharmacies.
  • Oilatum® 634 mg/g Bath emulsion indicated for local treatment of irritated, dry, itchy, and flaking skin, also indicated for infant bathing. Sold OTC through Polish pharmacies.
  • Permen® Med Forte Used for treating erectile dysfunction in adult men, defined as the inability to obtain or maintain sufficient penile erection for sexual intercourse. Sold OTC through Polish pharmacies.
  • Venoruton® forte Tablet medication that protects venous vessels, stabilizes venous walls, and reduces edema. Used for leg edema, venous insufficiency (leg varicose veins), and hemorrhoids. Sold OTC through Polish pharmacies.
  • Dabigatran Eteksylan STADA Available in 75mg, 110mg, and 150mg hard capsule forms (Dabigatranum etexilatum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.
  • Palexia Retard Available in 50mg, 100mg, 150mg, 200mg, and 250mg extended-release tablet forms (Tapentadol), an analgesic for moderate to severe pain. Dispensed by prescription through Polish pharmacies.
  • Tramal/Tramal Retard Tramadol hydrochloride products available as oral drops (10ml, 96ml) and extended-release tablets (50mg, 100mg, 150mg, 200mg), an analgesic. Dispensed by prescription through Polish pharmacies.
  • Transtec Transdermal patch system available in 35μg/h, 52.5μg/h, and 70μg/h doses (Buprenorphinum), for pain management. Dispensed by prescription through Polish pharmacies.
  • Versatis 700mg medicated plaster (Lidocainum) for topical pain relief. Dispensed by prescription through Polish pharmacies.
  • Axipio Available in 2.5mg and 5mg film-coated tablets (Apixabanum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.
  • Lecytyna Forte 1200mg lecithin supplement for cognitive function support, sold through Polish pharmacies as a dietary supplement.
  • Ximluci (Ranibizumab) 10 mg/ml solution for injection, administered by qualified ophthalmologists for intravitreal injections. Dispensed by prescription through specialist ophthalmology channels in Poland.
  • Zaldiar 37.5/325mg film-coated tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.
  • Zaldiar Effervescent 37.5/325mg effervescent tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.
  • Kefdensis 60mg Denosumab solution for injection in pre-filled syringes for osteoporosis treatment. Dispensed by prescription through Polish pharmacies and clinics.
  • Kinpeygo 4mg Budesonide modified-release hard capsules for kidney disease treatment. Dispensed by prescription through Polish pharmacies and clinics.
  • Posaconazole Stada 40 mg/ml oral suspension (Posaconazolum), an antifungal medication. Dispensed by prescription through Polish pharmacies.
  • Flexove 625mg Glucosamine film-coated tablets for joint health. Dispensed by prescription through Polish pharmacies.
  • Dobroson 7.5mg Zopiclone film-coated tablets for sleep disorders. Dispensed by prescription through Polish pharmacies.
  • Acodin® Junior Syrup containing 7.5mg dextromethorphan hydrobromide and 50mg dexpanthenol per 5ml for cough treatment in children. Dispensed by prescription through Polish pharmacies.
  • Sinulan Express Forte Product for nasal/sinus relief distributed through Polish pharmacies as a medical device.
  • Sinulan Express Forte Junior Junior version of sinus relief product distributed through Polish pharmacies as a medical device.
  • Hedrin® OCHRONA Head lice protection product distributed through Polish pharmacies as a medical device.
  • Hedrin® SZAMPON Medicated shampoo for head lice treatment distributed through Polish pharmacies as a medical device.
  • Hedrin® RAZ Head lice treatment product in gel form distributed through Polish pharmacies as a medical device.
  • Nizoral® Daily Care odżywka Nizoral daily conditioner for hair care, sold through Polish pharmacies as a cosmetic.
  • Nizoral® Daily Care Szampon Nizoral daily shampoo for regular hair and scalp care, sold through Polish pharmacies as a cosmetic.
  • Oilatum® Formuła Zaawansowana Emulsja Advanced formula bath emulsion for sensitive and dry skin, sold through Polish pharmacies as a cosmetic.
  • Oilatum® Formuła MED. Krem Medical formula cream for dry and sensitive skin, sold through Polish pharmacies as a cosmetic.
  • Oilatum® Codzienna Ochrona Emolient w kostce Daily protection emollient soap bar for gentle cleansing, sold through Polish pharmacies as a cosmetic.
  • Oilatum® Codzienna Ochrona Płyn do kąpieli Daily protection bath liquid for moisturizing and skin protection, sold through Polish pharmacies as a cosmetic.
  • Oilatum® Codzienna Ochrona Żel do mycia głowy i ciała Daily protection head and body wash gel for gentle cleansing, sold through Polish pharmacies as a cosmetic.
  • Sinulan Forte Plant-based preparation supporting proper functioning of the upper respiratory tract, sold through Polish pharmacies as a dietary supplement.
  • Sinulan Duo Forte Dual-action formula for respiratory tract support, sold through Polish pharmacies as a dietary supplement.
  • Biotyna 300 µg Biotin supplement containing 300 mcg per tablet, sold through Polish pharmacies as a dietary supplement.
  • Omega 3-6-9 Combined omega-3, omega-6, and omega-9 fatty acid supplement, sold through Polish pharmacies as a dietary supplement.
  • Selen Organiczny Organic selenium supplement containing 100 mcg per tablet, sold through Polish pharmacies as a dietary supplement.
  • Sylimarin Max Maximum strength silymarin supplement (150mg) for liver support, sold through Polish pharmacies as a dietary supplement.
  • Urinal Intensiv Intensive urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.
  • Urinal Standard urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.
  • Witamina D3 2000 Vitamin D3 supplement providing 2000 IU per tablet, sold through Polish pharmacies as a dietary supplement.
  • Lactostad dla dzieci Probiotic supplement designed for children, sold through Polish pharmacies as a dietary supplement.
  • Lactostad dla dorosłych Probiotic supplement designed for adults, sold through Polish pharmacies as a dietary supplement.
  • Sinulan plaster aromatyczny Junior Aromatic nasal strip for children for easier breathing during colds, sold through Polish pharmacies.

Companies that use STADA Poland

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

STADA Poland technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

STADA Poland partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • NEUCAcoreChannel Partner/ Reseller/ Distributor · 13 September 2021NEUCA is the largest pharmaceutical wholesaler in Poland. STADA Poland was the General Partner (Partner Generalny) at the Gala Farmaceuty organized by NEUCA in September 2021 at the Warsaw Hilton hotel. The event was attended by 280 owners representing nearly 1,000 pharmacies, providing STADA with opportunities to showcase its product portfolio and build long-term customer relationships.
  • SanoficoreOthers · 1 October 2020STADA finalized the acquisition of approximately a dozen consumer brands from Sanofi in 13 European countries. In Poland, the acquired brands include Modafen and Acodin. The transaction did not include production assets or employees.
  • GlaxoSmithKline (GSK)coreOthers · 1 June 2020STADA acquired from GSK a portfolio of 15 OTC products in over 50 countries globally. In Poland, this included the brands Orofar, Cholinex, and Venoruton, significantly expanding STADA Poland's consumer healthcare portfolio.
  • WalmarkcoreOthers · 1 March 2020Walmark merged with STADA in March 2020. This merger consolidated employees who were previously working in three different locations into a single unified office under the One STADA philosophy. The Walmark portfolio included brands such as Sinulan Forte and Lactostad.
  • AlvotechcoreStrategic or Co-development PartnerAlvotech is a biotech company specializing in biosimilar development. STADA collaborates with Alvotech as part of its biosimilar research program aimed at becoming a key player in the biosimilar segment, particularly for oncology treatments such as filgrastim and pegfilgrastym.
  • mAbxience (Insud)coreStrategic or Co-development PartnerPart of STADA's biosimilar development collaboration program. mAbxience specializes in biosimilar monoclonal antibodies. STADA aims to leverage this partnership to expand its presence in the biosimilar segment.
  • XbranecoreStrategic or Co-development PartnerXbrane collaborates with STADA on biosimilar development. This partnership is part of STADA's strategy to build capabilities in the biosimilar market segment.
  • Johnson & JohnsoncoreOthersSTADA acquired the Nizoral brand from Johnson & Johnson as part of its expansion of the consumer healthcare portfolio in Poland.
  • KantarminorOthersKantar is the market research agency commissioned by STADA to conduct the annual STADA Health Report. The 2021 edition surveyed 30,000 respondents from 15 European countries including Poland on health-related topics including pandemic effects on daily life.

Scale indicators6 records

Recent moves8 records

Expansion highlights4 records

STADA Poland competitors and assessment

Company assessment

Direct peers

  • Polpharma: Poland's largest generic pharmaceutical manufacturer, producing prescription generics, OTC, and dietary supplements with a similarly broad therapeutic portfolio and pharmacy-led distribution model — directly comparable to STADA Poland's two-pillar strategy.
  • Teva Poland: Teva is the world's leading generics company and a top-tier player in the Polish prescription generic and specialty market. It competes head-on with STADA Poland across therapeutic categories and pharmacy channels.
  • Sandoz Poland (Novartis): Sandoz is Novartis's generics division and a major prescription generic and biosimilar competitor in Poland. It mirrors STADA Poland's generic-plus-specialty positioning, particularly in biosimilars.
  • KRKA Poland: KRKA is a Slovenian generic and OTC pharmaceutical group with a strong Polish subsidiary. It competes with STADA Poland across prescription generics, OTC, and self-medication categories.
  • Gedeon Richter Poland: Gedeon Richter's Polish subsidiary markets a broad portfolio of generics and specialty pharmaceuticals, including CNS and women's health. It is a comparable Eastern European generic peer with similar pharmacy-led distribution.
  • Viatris Poland (formerly Mylan): Viatris is a global generics and specialty player with a Polish commercial presence, directly competing with STADA Poland in generic prescriptions and selected OTC categories.
  • Zentiva Poland: Zentiva (formerly Sanofi's European generics business) is a pan-European generic manufacturer with a Polish footprint, directly competing with STADA Poland across generic Rx and self-medication.

Regional players

  • USP Zdrowie (Pelion): USP Zdrowie is a major Polish OTC, supplement, and cosmetics manufacturer, part of the Pelion group that also operates the CEPD/wholesale network. It is a strong domestic peer with overlapping OTC and dietary supplement categories.
  • Aflofarm Poland: Aflofarm is one of the leading Polish OTC and dietary supplement manufacturers with strong domestic brands (e.g., Apap, Strepsils-adjacent SKUs). It is a regional OTC/supplement peer that competes for pharmacy shelf space and consumer mindshare.

Broad incumbents

  • Perrigo Poland: Perrigo is a global OTC and self-care leader; its Polish subsidiary markets OTC and consumer healthcare products (e.g., Analgesics, cold & flu). It is a broad incumbent comparable in OTC portfolio shape and pharmacy-channel go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

STADA Poland social profiles

Digital presence

STADA Poland compliance and trust

Trust signal

Compliance2 records

STADA Poland financial estimates

Financial estimate

Revenue estimate

Valuation estimate

STADA Poland leadership team

Management profile

Number of profiles

Profiles3 records

STADA Poland funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

STADA Poland M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STADA Poland

What does STADA Poland do?

STADA Poland develops and markets a two-pillar portfolio of (1) generic and specialty prescription medicines covering pain, cardiovascular, CNS, urology, oncology, and infectious disease therapeutics, and (2) consumer healthcare OTC products, medical devices, cosmetics, and dietary supplements. Its products are sold through pharmaceutical wholesalers and pharmacy retail in Poland under established brands such as Cholinex, Orofar, Nizoral, ITAMI, Venoruton, Mobilat, Hirudoid, Oilatum, Sinulan, and Hedrin.

Is STADA Poland a public or private company?

STADA Poland is a private company. It is classified as corporate owned and is currently operating.

When was STADA Poland founded?

STADA Poland was founded in -1. It employs 101 to 250 people.

Where is STADA Poland based?

STADA Poland is headquartered in Warszawa, Poland, in the Europe region.

How does STADA Poland make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are STADA Poland's main competitors?

Direct peers on record are Polpharma, Teva Poland, Sandoz Poland (Novartis), KRKA Poland, Gedeon Richter Poland, Viatris Poland (formerly Mylan) and Zentiva Poland. Regional players are USP Zdrowie (Pelion) and Aflofarm Poland. Perrigo Poland is listed as a broad incumbent.

Does STADA Poland have an API?

No public API is recorded for STADA Poland.

What industry is STADA Poland in?

STADA Poland's product category is Generic and specialty pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales